Quality of Life Linked with Physical, Psychological Symptoms in Cancer
the Cancer Therapy Advisor take:
Quality of life (QoL) was found to be linked to physical and psychological symptoms in patients with advanced cancer, according to an article published online in the journal European Journal of Cancer Care.
In this study, 115 patients with cancer were evaluating using a series of rating scales including the Functional Assessment of Chronic Illness Therapy – Spiritual Well-Being Scale, the Hospital Anxiety and Depression Scale, the Visual Analogue Scale for pain, the Brief Coping Orientation to Problem Experienced and the Functional Assessment of Cancer Therapy Scale – General Measure.
Results showed workers and single patients with higher level education demonstrated a worse QoL compared to their counterparts.
Furthermore, QoL was negatively associated with pain and anxiety, but positively associated with spirituality and ‘Instrumental Support’ coping style.
The authors noted that when patients were close to death in the Italian sample, they relied heavily on faith as a component of spirituality rather than meaning or peace.
Quality of life was found to be linked to physical and psychological symptoms in patients with advanced cancer.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
- Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome
- Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
- First-Line Pembrolizumab Shows Promise in Non-Clear Cell RCC
- Early Tumor Shrinkage With Cabozantinib Improves Survival in Renal Cell Carcinoma
- Combo Superior to Sunitinib in Advanced Renal Cell Carcinoma
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed